As president of Takeda Global R&D, Center, US, Dr Nabulsi directs all aspects of Takeda’s US drug development activities, including the identification of new product candidates, execution of clinical trial programs and support for innovative lifecycle management approaches for Takeda’s marketed products.
Under Dr Nabulsi’s leadership, Takeda’s US development activities will continue to be a strong component in helping the organization to achieve the vision of having leading development capabilities within the pharmaceutical industry, the company said.
Having previously held the position of general manager for Takeda’s strategic development department based in Osaka, Japan, Dr Nabulsi was responsible for overseeing Takeda’s global portfolio strategies, development plans, and performance and productivity initiatives. Prior to that, Dr Nabulsi held roles within R&D operations for Takeda Global R&D Center, US.